Molecular Testing for Fragile X: Analysis of 5062 Tests from 1105 Fragile X Families—Performed in 12 Clinical Laboratories in Spain

Table 2

Medical indication for referral.

	Number of males	Number of females	Total number
Patients with ID
With family history of ID
GDD, ID, and autism (all ages)	97	8	105
Studies in ID institutions	22	0	22
With no family history of ID
Children with GDD and or autism	461	55	516
ID in young patients and adults	113	13	126
Patients with normal intelligence
With family history of ID
Relative of a patient with FXS diagnosed in another centre	30	112	142
Individual with history of ID with unknown aetiology in his/her family	2	16	18
With no family history of ID
POI and/or menopause	0	17	17
FXTAS	10	3	13
Unknown reason to be studied	106	40	146
Total	841	264	1105